This is an archived article that was published on sltrib.com in 2015, and information in the article may be outdated. It is provided only for personal research purposes and may not be reprinted.
Washington • The cost of prescription skin treatments has skyrocketed since 2009 as the burden of escalating drug prices increasingly weighs on family budgets.
Retail prices have surged 401 percent since 2009 for brand-name drugs for skin conditions, according to research published in JAMA Dermatology, a medical journal.
Of the 19 brand-name drugs analyzed in the study published Wednesday, price hikes have been most extreme for two drugs made by Valeant Pharmaceuticals International Inc., which has been subpoenaed by federal prosecutors for documents tied to its pricing and practices.
Costs for Valeant's Targretin gel skin cancer treatment have shot up 18-fold over the past six years to $30,320 per 60 gram tube. Prices for a separate Valeant skin cancer cream, Carac cream, also surged 18 times to $2,865 for a 30 gram tube.
But the study found that dramatic price hikes are common in the pharmaceutical industry.